Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Dr. AJ Headshot 4x5sm-Speak.jpg

    MJFF Research Fellow Works to ‘Untangle the Roots’ of Medical Mistrust and Clinical Trial Participation

    To help understand the complex barriers to research participation, we spoke with Michael J. Fox Foundation Research Fellow — a partnership with the Community Access, Recruitment and Engagement (CARE)…
    Learn more

  • The State of the Science of Parkinson's Research

    What We Fund: Expanding Our Landmark Study and Studying a New Parkinson’s Gene

    Our bimonthly report shares highlights from 36 new grants totaling $6.3 million in April and May including efforts to make our PPMI study more inclusive and to study a gene that may work with LRRK2…
    Learn more

  • Ogden_Lab board.jpg

    What Does the New Alzheimer’s Drug Mean for People with Parkinson’s?

    Learn what the recent approval of a new Alzheimer’s drug — the first in almost two decades — might mean for you and your loved one.
    Learn more

  • Scientist in lab holding up blood sample

    PPMI Dispatch: Meeting of the Study Minds and Clues on Cognitive Change

    More than 300 study partners met virtually for the annual PPMI meeting to discuss challenges, opportunities and future plans while scientists continue to report out from study analysis.
    Learn more

  • Doctor and two people in office

    Research Roundup: Studies Need a Wide Range of Participants to Bring Us Closer to Cures

    Four Parkinson’s studies are recruiting people with and without Parkinson’s disease.
    Learn more

  • Ogden Test Tube.jpg

    News in Context: New Drug Approved for Alzheimer’s Disease “Is a Real Signal to Research and Patient Communities”

    In a significant milestone making waves among researchers and people living with brain disease, aducanumab became the first Alzheimer’s drug approved in nearly 20 years and the first to be approved…
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.